Market Talk
The GDP number came out slightly sluggish, but not alarming. It probably supports the notion of further rate cuts on the way. Still suggest to maintain some dry Powder in case the "soft landing"
notion switches to a harder knock on the head.
Stock Talk
First, a note to stay consistent. Yesterday, I highlighted a post on Ramaco Resources, but later removed it. Recall we had a near double on METC in the past but let it go after it faded quick from the 20's on insider selling. Last night, after further review, decided to keep the bullish notions on hold because the bread 'n butter, coking coal for steel, is not estimated to have the returns of last year. Some analysts are projecting an earnings loss this quarter . It is still possible they will surprise or an update on REE plans will help the outlook. Ramaco seems like a good stock to watch, perhaps from the sidelines to see how the earnings and subsequent outlook seem.
There are two new speculative stocks catching some interest. I will point them out for interested readers to look into further if you dare.
Two stocks to Watch:
ASP Isotopes (ASPI) : A potential partnership with Bill Gates involved Terra Power (LLC) is capturing interest in ASPI. We mentioned yesterday, this one may have a fair chance at further upside with a few "some" speculative shares. It's moving higher, still in single digit range. ASPI [update 11/03] has a cutting edge process using lasers for enriching Uranium for nuclear Power generation and other elements for medical and advanced semi conductors.
https://finance.yahoo.com/m/f086639d-4530-3930-974f-614981f46094/asp-isotopes-stock-surges-on.html
Terns Pharmaceuticals (TERN) : Last month, TERN saw a lot of insider buying. Yet the stock still faded down some in share price. The company has a weight loss drug that resulted in faster weight loss with more fat loss than muscle in an early trial. It is early and speculative which raises risk. However, it is reported to have high insider ownership that institutions favor.
https://finance.yahoo.com/news/terns-pharmaceuticals-oral-glp-1-132450455.html
For now, we close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time. But trying to look ahead a few months into the future may be a way to do things. If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. In all - we use the word maybe "some", not "too much" and play it accordingly. Remember, never get arrogant in our various notions because things do change in the market and individual stocks are subject to many factors outside of our control.. So we try to -stay aware.
With all the above caveats and attempted prognostications, I will close this post. Stay tuned for more opining on the market and stocks to watch.
________
